nodes	percent_of_prediction	percent_of_DWPC	metapath
Fenofibrate—CYP2C8—Ifosfamide—testicular cancer	0.161	0.289	CbGbCtD
Fenofibrate—CYP2C9—Ifosfamide—testicular cancer	0.112	0.202	CbGbCtD
Fenofibrate—CYP2C8—Etoposide—testicular cancer	0.0768	0.138	CbGbCtD
Fenofibrate—CYP3A4—Ifosfamide—testicular cancer	0.0652	0.117	CbGbCtD
Fenofibrate—CYP2C9—Cisplatin—testicular cancer	0.0545	0.098	CbGbCtD
Fenofibrate—CYP3A4—Vinblastine—testicular cancer	0.0346	0.0622	CbGbCtD
Fenofibrate—CYP3A4—Etoposide—testicular cancer	0.0312	0.056	CbGbCtD
Fenofibrate—CYP3A4—Doxorubicin—testicular cancer	0.0212	0.0382	CbGbCtD
Fenofibrate—Gastrointestinal disorder—Etoposide—testicular cancer	0.000327	0.000736	CcSEcCtD
Fenofibrate—Body temperature increased—Cisplatin—testicular cancer	0.000326	0.000736	CcSEcCtD
Fenofibrate—Fatigue—Etoposide—testicular cancer	0.000326	0.000735	CcSEcCtD
Fenofibrate—Jaundice—Epirubicin—testicular cancer	0.000324	0.00073	CcSEcCtD
Fenofibrate—Pain—Etoposide—testicular cancer	0.000324	0.000729	CcSEcCtD
Fenofibrate—Constipation—Etoposide—testicular cancer	0.000324	0.000729	CcSEcCtD
Fenofibrate—Conjunctivitis—Epirubicin—testicular cancer	0.000323	0.000728	CcSEcCtD
Fenofibrate—Urinary tract infection—Epirubicin—testicular cancer	0.000323	0.000728	CcSEcCtD
Fenofibrate—Dysuria—Doxorubicin—testicular cancer	0.000323	0.000727	CcSEcCtD
Fenofibrate—Upper respiratory tract infection—Doxorubicin—testicular cancer	0.000321	0.000723	CcSEcCtD
Fenofibrate—Hepatitis—Methotrexate—testicular cancer	0.000319	0.000719	CcSEcCtD
Fenofibrate—Sweating—Epirubicin—testicular cancer	0.000319	0.000718	CcSEcCtD
Fenofibrate—Pollakiuria—Doxorubicin—testicular cancer	0.000319	0.000718	CcSEcCtD
Fenofibrate—Dizziness—Ifosfamide—testicular cancer	0.000317	0.000714	CcSEcCtD
Fenofibrate—Pharyngitis—Methotrexate—testicular cancer	0.000317	0.000713	CcSEcCtD
Fenofibrate—Photosensitivity reaction—Doxorubicin—testicular cancer	0.000315	0.00071	CcSEcCtD
Fenofibrate—Hepatobiliary disease—Epirubicin—testicular cancer	0.000314	0.000709	CcSEcCtD
Fenofibrate—Weight increased—Doxorubicin—testicular cancer	0.000314	0.000708	CcSEcCtD
Fenofibrate—Weight decreased—Doxorubicin—testicular cancer	0.000312	0.000704	CcSEcCtD
Fenofibrate—Sinusitis—Epirubicin—testicular cancer	0.000312	0.000703	CcSEcCtD
Fenofibrate—Feeling abnormal—Etoposide—testicular cancer	0.000312	0.000703	CcSEcCtD
Fenofibrate—Nausea—Dactinomycin—testicular cancer	0.00031	0.0007	CcSEcCtD
Fenofibrate—Pneumonia—Doxorubicin—testicular cancer	0.000309	0.000697	CcSEcCtD
Fenofibrate—Gastrointestinal pain—Etoposide—testicular cancer	0.000309	0.000697	CcSEcCtD
Fenofibrate—Infestation NOS—Doxorubicin—testicular cancer	0.000308	0.000693	CcSEcCtD
Fenofibrate—Infestation—Doxorubicin—testicular cancer	0.000308	0.000693	CcSEcCtD
Fenofibrate—Visual impairment—Methotrexate—testicular cancer	0.000307	0.000693	CcSEcCtD
Fenofibrate—Vomiting—Ifosfamide—testicular cancer	0.000305	0.000686	CcSEcCtD
Fenofibrate—Hypersensitivity—Cisplatin—testicular cancer	0.000304	0.000686	CcSEcCtD
Fenofibrate—Renal failure—Doxorubicin—testicular cancer	0.000302	0.000682	CcSEcCtD
Fenofibrate—Rash—Ifosfamide—testicular cancer	0.000302	0.000681	CcSEcCtD
Fenofibrate—Dermatitis—Ifosfamide—testicular cancer	0.000302	0.00068	CcSEcCtD
Fenofibrate—Urticaria—Etoposide—testicular cancer	0.000301	0.000677	CcSEcCtD
Fenofibrate—Jaundice—Doxorubicin—testicular cancer	0.0003	0.000676	CcSEcCtD
Fenofibrate—Rhinitis—Epirubicin—testicular cancer	0.000299	0.000674	CcSEcCtD
Fenofibrate—Abdominal pain—Etoposide—testicular cancer	0.000299	0.000674	CcSEcCtD
Fenofibrate—Body temperature increased—Etoposide—testicular cancer	0.000299	0.000674	CcSEcCtD
Fenofibrate—Conjunctivitis—Doxorubicin—testicular cancer	0.000299	0.000674	CcSEcCtD
Fenofibrate—Urinary tract infection—Doxorubicin—testicular cancer	0.000299	0.000674	CcSEcCtD
Fenofibrate—Hepatitis—Epirubicin—testicular cancer	0.000298	0.000673	CcSEcCtD
Fenofibrate—Eye disorder—Methotrexate—testicular cancer	0.000298	0.000672	CcSEcCtD
Fenofibrate—Asthenia—Cisplatin—testicular cancer	0.000296	0.000668	CcSEcCtD
Fenofibrate—Pharyngitis—Epirubicin—testicular cancer	0.000296	0.000668	CcSEcCtD
Fenofibrate—Cardiac disorder—Methotrexate—testicular cancer	0.000296	0.000667	CcSEcCtD
Fenofibrate—Sweating—Doxorubicin—testicular cancer	0.000295	0.000665	CcSEcCtD
Fenofibrate—Oedema peripheral—Epirubicin—testicular cancer	0.000294	0.000663	CcSEcCtD
Fenofibrate—Connective tissue disorder—Epirubicin—testicular cancer	0.000293	0.000661	CcSEcCtD
Fenofibrate—Hepatobiliary disease—Doxorubicin—testicular cancer	0.000291	0.000656	CcSEcCtD
Fenofibrate—Angiopathy—Methotrexate—testicular cancer	0.000289	0.000652	CcSEcCtD
Fenofibrate—Sinusitis—Doxorubicin—testicular cancer	0.000289	0.000651	CcSEcCtD
Fenofibrate—Visual impairment—Epirubicin—testicular cancer	0.000288	0.000648	CcSEcCtD
Fenofibrate—Mediastinal disorder—Methotrexate—testicular cancer	0.000287	0.000648	CcSEcCtD
Fenofibrate—Nausea—Ifosfamide—testicular cancer	0.000285	0.000641	CcSEcCtD
Fenofibrate—Diarrhoea—Cisplatin—testicular cancer	0.000283	0.000637	CcSEcCtD
Fenofibrate—Alopecia—Methotrexate—testicular cancer	0.000282	0.000635	CcSEcCtD
Fenofibrate—Mental disorder—Methotrexate—testicular cancer	0.000279	0.00063	CcSEcCtD
Fenofibrate—Eye disorder—Epirubicin—testicular cancer	0.000279	0.000629	CcSEcCtD
Fenofibrate—Hypersensitivity—Etoposide—testicular cancer	0.000279	0.000628	CcSEcCtD
Fenofibrate—Malnutrition—Methotrexate—testicular cancer	0.000278	0.000626	CcSEcCtD
Fenofibrate—Erythema—Methotrexate—testicular cancer	0.000278	0.000626	CcSEcCtD
Fenofibrate—Cardiac disorder—Epirubicin—testicular cancer	0.000277	0.000624	CcSEcCtD
Fenofibrate—Rhinitis—Doxorubicin—testicular cancer	0.000277	0.000624	CcSEcCtD
Fenofibrate—Hepatitis—Doxorubicin—testicular cancer	0.000276	0.000622	CcSEcCtD
Fenofibrate—Pharyngitis—Doxorubicin—testicular cancer	0.000274	0.000618	CcSEcCtD
Fenofibrate—Oedema peripheral—Doxorubicin—testicular cancer	0.000272	0.000613	CcSEcCtD
Fenofibrate—Asthenia—Etoposide—testicular cancer	0.000271	0.000612	CcSEcCtD
Fenofibrate—Connective tissue disorder—Doxorubicin—testicular cancer	0.000271	0.000612	CcSEcCtD
Fenofibrate—Angiopathy—Epirubicin—testicular cancer	0.000271	0.00061	CcSEcCtD
Fenofibrate—Mediastinal disorder—Epirubicin—testicular cancer	0.000269	0.000606	CcSEcCtD
Fenofibrate—Back pain—Methotrexate—testicular cancer	0.000269	0.000605	CcSEcCtD
Fenofibrate—Pruritus—Etoposide—testicular cancer	0.000268	0.000603	CcSEcCtD
Fenofibrate—Arrhythmia—Epirubicin—testicular cancer	0.000267	0.000601	CcSEcCtD
Fenofibrate—Visual impairment—Doxorubicin—testicular cancer	0.000266	0.0006	CcSEcCtD
Fenofibrate—Alopecia—Epirubicin—testicular cancer	0.000264	0.000594	CcSEcCtD
Fenofibrate—Vomiting—Cisplatin—testicular cancer	0.000263	0.000592	CcSEcCtD
Fenofibrate—Mental disorder—Epirubicin—testicular cancer	0.000262	0.000589	CcSEcCtD
Fenofibrate—Rash—Cisplatin—testicular cancer	0.00026	0.000587	CcSEcCtD
Fenofibrate—Dermatitis—Cisplatin—testicular cancer	0.00026	0.000586	CcSEcCtD
Fenofibrate—Malnutrition—Epirubicin—testicular cancer	0.00026	0.000586	CcSEcCtD
Fenofibrate—Erythema—Epirubicin—testicular cancer	0.00026	0.000586	CcSEcCtD
Fenofibrate—Diarrhoea—Etoposide—testicular cancer	0.000259	0.000583	CcSEcCtD
Fenofibrate—Eye disorder—Doxorubicin—testicular cancer	0.000258	0.000582	CcSEcCtD
Fenofibrate—Ill-defined disorder—Methotrexate—testicular cancer	0.000258	0.000581	CcSEcCtD
Fenofibrate—Anaemia—Methotrexate—testicular cancer	0.000257	0.000578	CcSEcCtD
Fenofibrate—Cardiac disorder—Doxorubicin—testicular cancer	0.000256	0.000578	CcSEcCtD
Fenofibrate—Flatulence—Epirubicin—testicular cancer	0.000256	0.000577	CcSEcCtD
Fenofibrate—Tension—Epirubicin—testicular cancer	0.000255	0.000575	CcSEcCtD
Fenofibrate—Nervousness—Epirubicin—testicular cancer	0.000252	0.000569	CcSEcCtD
Fenofibrate—Back pain—Epirubicin—testicular cancer	0.000251	0.000566	CcSEcCtD
Fenofibrate—Angiopathy—Doxorubicin—testicular cancer	0.000251	0.000565	CcSEcCtD
Fenofibrate—Malaise—Methotrexate—testicular cancer	0.00025	0.000564	CcSEcCtD
Fenofibrate—Dizziness—Etoposide—testicular cancer	0.00025	0.000564	CcSEcCtD
Fenofibrate—Muscle spasms—Epirubicin—testicular cancer	0.00025	0.000563	CcSEcCtD
Fenofibrate—Vertigo—Methotrexate—testicular cancer	0.000249	0.000562	CcSEcCtD
Fenofibrate—Mediastinal disorder—Doxorubicin—testicular cancer	0.000249	0.000561	CcSEcCtD
Fenofibrate—Leukopenia—Methotrexate—testicular cancer	0.000249	0.00056	CcSEcCtD
Fenofibrate—Arrhythmia—Doxorubicin—testicular cancer	0.000247	0.000556	CcSEcCtD
Fenofibrate—Nausea—Cisplatin—testicular cancer	0.000245	0.000553	CcSEcCtD
Fenofibrate—Alopecia—Doxorubicin—testicular cancer	0.000244	0.00055	CcSEcCtD
Fenofibrate—Cough—Methotrexate—testicular cancer	0.000242	0.000546	CcSEcCtD
Fenofibrate—Mental disorder—Doxorubicin—testicular cancer	0.000242	0.000545	CcSEcCtD
Fenofibrate—Ill-defined disorder—Epirubicin—testicular cancer	0.000241	0.000543	CcSEcCtD
Fenofibrate—Vomiting—Etoposide—testicular cancer	0.000241	0.000542	CcSEcCtD
Fenofibrate—Erythema—Doxorubicin—testicular cancer	0.00024	0.000542	CcSEcCtD
Fenofibrate—Malnutrition—Doxorubicin—testicular cancer	0.00024	0.000542	CcSEcCtD
Fenofibrate—Anaemia—Epirubicin—testicular cancer	0.00024	0.000541	CcSEcCtD
Fenofibrate—Rash—Etoposide—testicular cancer	0.000239	0.000538	CcSEcCtD
Fenofibrate—Dermatitis—Etoposide—testicular cancer	0.000238	0.000537	CcSEcCtD
Fenofibrate—Headache—Etoposide—testicular cancer	0.000237	0.000534	CcSEcCtD
Fenofibrate—Flatulence—Doxorubicin—testicular cancer	0.000237	0.000534	CcSEcCtD
Fenofibrate—Arthralgia—Methotrexate—testicular cancer	0.000236	0.000533	CcSEcCtD
Fenofibrate—Chest pain—Methotrexate—testicular cancer	0.000236	0.000533	CcSEcCtD
Fenofibrate—Myalgia—Methotrexate—testicular cancer	0.000236	0.000533	CcSEcCtD
Fenofibrate—Tension—Doxorubicin—testicular cancer	0.000236	0.000532	CcSEcCtD
Fenofibrate—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—testicular cancer	0.000235	0.000529	CcSEcCtD
Fenofibrate—Malaise—Epirubicin—testicular cancer	0.000234	0.000528	CcSEcCtD
Fenofibrate—Discomfort—Methotrexate—testicular cancer	0.000234	0.000526	CcSEcCtD
Fenofibrate—Nervousness—Doxorubicin—testicular cancer	0.000234	0.000526	CcSEcCtD
Fenofibrate—Vertigo—Epirubicin—testicular cancer	0.000233	0.000526	CcSEcCtD
Fenofibrate—Leukopenia—Epirubicin—testicular cancer	0.000233	0.000524	CcSEcCtD
Fenofibrate—Back pain—Doxorubicin—testicular cancer	0.000233	0.000524	CcSEcCtD
Fenofibrate—Muscle spasms—Doxorubicin—testicular cancer	0.000231	0.000521	CcSEcCtD
Fenofibrate—Palpitations—Epirubicin—testicular cancer	0.00023	0.000518	CcSEcCtD
Fenofibrate—Cough—Epirubicin—testicular cancer	0.000227	0.000511	CcSEcCtD
Fenofibrate—Infection—Methotrexate—testicular cancer	0.000225	0.000507	CcSEcCtD
Fenofibrate—Nausea—Etoposide—testicular cancer	0.000225	0.000506	CcSEcCtD
Fenofibrate—Hypertension—Epirubicin—testicular cancer	0.000224	0.000506	CcSEcCtD
Fenofibrate—Ill-defined disorder—Doxorubicin—testicular cancer	0.000223	0.000503	CcSEcCtD
Fenofibrate—Nervous system disorder—Methotrexate—testicular cancer	0.000222	0.000501	CcSEcCtD
Fenofibrate—Anaemia—Doxorubicin—testicular cancer	0.000222	0.000501	CcSEcCtD
Fenofibrate—Thrombocytopenia—Methotrexate—testicular cancer	0.000222	0.0005	CcSEcCtD
Fenofibrate—Arthralgia—Epirubicin—testicular cancer	0.000221	0.000499	CcSEcCtD
Fenofibrate—Chest pain—Epirubicin—testicular cancer	0.000221	0.000499	CcSEcCtD
Fenofibrate—Myalgia—Epirubicin—testicular cancer	0.000221	0.000499	CcSEcCtD
Fenofibrate—Anxiety—Epirubicin—testicular cancer	0.00022	0.000497	CcSEcCtD
Fenofibrate—Skin disorder—Methotrexate—testicular cancer	0.00022	0.000496	CcSEcCtD
Fenofibrate—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—testicular cancer	0.00022	0.000495	CcSEcCtD
Fenofibrate—Hyperhidrosis—Methotrexate—testicular cancer	0.000219	0.000494	CcSEcCtD
Fenofibrate—Discomfort—Epirubicin—testicular cancer	0.000219	0.000493	CcSEcCtD
Fenofibrate—Malaise—Doxorubicin—testicular cancer	0.000217	0.000489	CcSEcCtD
Fenofibrate—Dry mouth—Epirubicin—testicular cancer	0.000216	0.000488	CcSEcCtD
Fenofibrate—Vertigo—Doxorubicin—testicular cancer	0.000216	0.000487	CcSEcCtD
Fenofibrate—Anorexia—Methotrexate—testicular cancer	0.000216	0.000487	CcSEcCtD
Fenofibrate—Leukopenia—Doxorubicin—testicular cancer	0.000215	0.000485	CcSEcCtD
Fenofibrate—Palpitations—Doxorubicin—testicular cancer	0.000212	0.000479	CcSEcCtD
Fenofibrate—Oedema—Epirubicin—testicular cancer	0.000212	0.000478	CcSEcCtD
Fenofibrate—Hypotension—Methotrexate—testicular cancer	0.000212	0.000477	CcSEcCtD
Fenofibrate—Infection—Epirubicin—testicular cancer	0.000211	0.000475	CcSEcCtD
Fenofibrate—Cough—Doxorubicin—testicular cancer	0.00021	0.000473	CcSEcCtD
Fenofibrate—Nervous system disorder—Epirubicin—testicular cancer	0.000208	0.000469	CcSEcCtD
Fenofibrate—Thrombocytopenia—Epirubicin—testicular cancer	0.000208	0.000468	CcSEcCtD
Fenofibrate—Hypertension—Doxorubicin—testicular cancer	0.000208	0.000468	CcSEcCtD
Fenofibrate—Tachycardia—Epirubicin—testicular cancer	0.000207	0.000466	CcSEcCtD
Fenofibrate—Musculoskeletal discomfort—Methotrexate—testicular cancer	0.000206	0.000465	CcSEcCtD
Fenofibrate—Skin disorder—Epirubicin—testicular cancer	0.000206	0.000464	CcSEcCtD
Fenofibrate—Hyperhidrosis—Epirubicin—testicular cancer	0.000205	0.000462	CcSEcCtD
Fenofibrate—Insomnia—Methotrexate—testicular cancer	0.000205	0.000462	CcSEcCtD
Fenofibrate—Chest pain—Doxorubicin—testicular cancer	0.000205	0.000461	CcSEcCtD
Fenofibrate—Arthralgia—Doxorubicin—testicular cancer	0.000205	0.000461	CcSEcCtD
Fenofibrate—Myalgia—Doxorubicin—testicular cancer	0.000205	0.000461	CcSEcCtD
Fenofibrate—Anxiety—Doxorubicin—testicular cancer	0.000204	0.00046	CcSEcCtD
Fenofibrate—Paraesthesia—Methotrexate—testicular cancer	0.000203	0.000459	CcSEcCtD
Fenofibrate—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—testicular cancer	0.000203	0.000458	CcSEcCtD
Fenofibrate—Discomfort—Doxorubicin—testicular cancer	0.000202	0.000456	CcSEcCtD
Fenofibrate—Anorexia—Epirubicin—testicular cancer	0.000202	0.000456	CcSEcCtD
Fenofibrate—Dyspnoea—Methotrexate—testicular cancer	0.000202	0.000455	CcSEcCtD
Fenofibrate—Somnolence—Methotrexate—testicular cancer	0.000201	0.000454	CcSEcCtD
Fenofibrate—Dry mouth—Doxorubicin—testicular cancer	0.0002	0.000451	CcSEcCtD
Fenofibrate—Dyspepsia—Methotrexate—testicular cancer	0.000199	0.00045	CcSEcCtD
Fenofibrate—Hypotension—Epirubicin—testicular cancer	0.000198	0.000447	CcSEcCtD
Fenofibrate—Decreased appetite—Methotrexate—testicular cancer	0.000197	0.000444	CcSEcCtD
Fenofibrate—Oedema—Doxorubicin—testicular cancer	0.000196	0.000442	CcSEcCtD
Fenofibrate—Gastrointestinal disorder—Methotrexate—testicular cancer	0.000196	0.000441	CcSEcCtD
Fenofibrate—Fatigue—Methotrexate—testicular cancer	0.000195	0.00044	CcSEcCtD
Fenofibrate—Infection—Doxorubicin—testicular cancer	0.000195	0.000439	CcSEcCtD
Fenofibrate—Pain—Methotrexate—testicular cancer	0.000194	0.000437	CcSEcCtD
Fenofibrate—Musculoskeletal discomfort—Epirubicin—testicular cancer	0.000193	0.000435	CcSEcCtD
Fenofibrate—Nervous system disorder—Doxorubicin—testicular cancer	0.000192	0.000434	CcSEcCtD
Fenofibrate—Thrombocytopenia—Doxorubicin—testicular cancer	0.000192	0.000433	CcSEcCtD
Fenofibrate—Insomnia—Epirubicin—testicular cancer	0.000192	0.000432	CcSEcCtD
Fenofibrate—Tachycardia—Doxorubicin—testicular cancer	0.000192	0.000432	CcSEcCtD
Fenofibrate—Skin disorder—Doxorubicin—testicular cancer	0.000191	0.00043	CcSEcCtD
Fenofibrate—Paraesthesia—Epirubicin—testicular cancer	0.00019	0.000429	CcSEcCtD
Fenofibrate—Hyperhidrosis—Doxorubicin—testicular cancer	0.00019	0.000428	CcSEcCtD
Fenofibrate—Dyspnoea—Epirubicin—testicular cancer	0.000189	0.000426	CcSEcCtD
Fenofibrate—Somnolence—Epirubicin—testicular cancer	0.000189	0.000425	CcSEcCtD
Fenofibrate—Anorexia—Doxorubicin—testicular cancer	0.000187	0.000422	CcSEcCtD
Fenofibrate—Feeling abnormal—Methotrexate—testicular cancer	0.000187	0.000421	CcSEcCtD
Fenofibrate—Dyspepsia—Epirubicin—testicular cancer	0.000187	0.000421	CcSEcCtD
Fenofibrate—Gastrointestinal pain—Methotrexate—testicular cancer	0.000185	0.000418	CcSEcCtD
Fenofibrate—Decreased appetite—Epirubicin—testicular cancer	0.000184	0.000415	CcSEcCtD
Fenofibrate—Hypotension—Doxorubicin—testicular cancer	0.000183	0.000413	CcSEcCtD
Fenofibrate—Gastrointestinal disorder—Epirubicin—testicular cancer	0.000183	0.000413	CcSEcCtD
Fenofibrate—Fatigue—Epirubicin—testicular cancer	0.000183	0.000412	CcSEcCtD
Fenofibrate—Pain—Epirubicin—testicular cancer	0.000181	0.000409	CcSEcCtD
Fenofibrate—Constipation—Epirubicin—testicular cancer	0.000181	0.000409	CcSEcCtD
Fenofibrate—Urticaria—Methotrexate—testicular cancer	0.00018	0.000406	CcSEcCtD
Fenofibrate—Body temperature increased—Methotrexate—testicular cancer	0.000179	0.000404	CcSEcCtD
Fenofibrate—Abdominal pain—Methotrexate—testicular cancer	0.000179	0.000404	CcSEcCtD
Fenofibrate—Musculoskeletal discomfort—Doxorubicin—testicular cancer	0.000179	0.000403	CcSEcCtD
Fenofibrate—Insomnia—Doxorubicin—testicular cancer	0.000177	0.0004	CcSEcCtD
Fenofibrate—Paraesthesia—Doxorubicin—testicular cancer	0.000176	0.000397	CcSEcCtD
Fenofibrate—Dyspnoea—Doxorubicin—testicular cancer	0.000175	0.000394	CcSEcCtD
Fenofibrate—Feeling abnormal—Epirubicin—testicular cancer	0.000175	0.000394	CcSEcCtD
Fenofibrate—Somnolence—Doxorubicin—testicular cancer	0.000174	0.000393	CcSEcCtD
Fenofibrate—Gastrointestinal pain—Epirubicin—testicular cancer	0.000173	0.000391	CcSEcCtD
Fenofibrate—Dyspepsia—Doxorubicin—testicular cancer	0.000173	0.000389	CcSEcCtD
Fenofibrate—Decreased appetite—Doxorubicin—testicular cancer	0.000171	0.000384	CcSEcCtD
Fenofibrate—Gastrointestinal disorder—Doxorubicin—testicular cancer	0.000169	0.000382	CcSEcCtD
Fenofibrate—Fatigue—Doxorubicin—testicular cancer	0.000169	0.000381	CcSEcCtD
Fenofibrate—Urticaria—Epirubicin—testicular cancer	0.000168	0.00038	CcSEcCtD
Fenofibrate—Constipation—Doxorubicin—testicular cancer	0.000168	0.000378	CcSEcCtD
Fenofibrate—Pain—Doxorubicin—testicular cancer	0.000168	0.000378	CcSEcCtD
Fenofibrate—Abdominal pain—Epirubicin—testicular cancer	0.000168	0.000378	CcSEcCtD
Fenofibrate—Body temperature increased—Epirubicin—testicular cancer	0.000168	0.000378	CcSEcCtD
Fenofibrate—Hypersensitivity—Methotrexate—testicular cancer	0.000167	0.000376	CcSEcCtD
Fenofibrate—Asthenia—Methotrexate—testicular cancer	0.000163	0.000366	CcSEcCtD
Fenofibrate—Feeling abnormal—Doxorubicin—testicular cancer	0.000162	0.000364	CcSEcCtD
Fenofibrate—Gastrointestinal pain—Doxorubicin—testicular cancer	0.00016	0.000362	CcSEcCtD
Fenofibrate—Pruritus—Methotrexate—testicular cancer	0.00016	0.000361	CcSEcCtD
Fenofibrate—Hypersensitivity—Epirubicin—testicular cancer	0.000156	0.000352	CcSEcCtD
Fenofibrate—Urticaria—Doxorubicin—testicular cancer	0.000156	0.000351	CcSEcCtD
Fenofibrate—Abdominal pain—Doxorubicin—testicular cancer	0.000155	0.00035	CcSEcCtD
Fenofibrate—Body temperature increased—Doxorubicin—testicular cancer	0.000155	0.00035	CcSEcCtD
Fenofibrate—Diarrhoea—Methotrexate—testicular cancer	0.000155	0.000349	CcSEcCtD
Fenofibrate—Asthenia—Epirubicin—testicular cancer	0.000152	0.000343	CcSEcCtD
Fenofibrate—Pruritus—Epirubicin—testicular cancer	0.00015	0.000338	CcSEcCtD
Fenofibrate—Dizziness—Methotrexate—testicular cancer	0.00015	0.000338	CcSEcCtD
Fenofibrate—Diarrhoea—Epirubicin—testicular cancer	0.000145	0.000327	CcSEcCtD
Fenofibrate—Hypersensitivity—Doxorubicin—testicular cancer	0.000145	0.000326	CcSEcCtD
Fenofibrate—Vomiting—Methotrexate—testicular cancer	0.000144	0.000325	CcSEcCtD
Fenofibrate—Rash—Methotrexate—testicular cancer	0.000143	0.000322	CcSEcCtD
Fenofibrate—Dermatitis—Methotrexate—testicular cancer	0.000143	0.000322	CcSEcCtD
Fenofibrate—Headache—Methotrexate—testicular cancer	0.000142	0.00032	CcSEcCtD
Fenofibrate—Asthenia—Doxorubicin—testicular cancer	0.000141	0.000317	CcSEcCtD
Fenofibrate—Dizziness—Epirubicin—testicular cancer	0.00014	0.000316	CcSEcCtD
Fenofibrate—Pruritus—Doxorubicin—testicular cancer	0.000139	0.000313	CcSEcCtD
Fenofibrate—Vomiting—Epirubicin—testicular cancer	0.000135	0.000304	CcSEcCtD
Fenofibrate—Nausea—Methotrexate—testicular cancer	0.000135	0.000303	CcSEcCtD
Fenofibrate—Diarrhoea—Doxorubicin—testicular cancer	0.000134	0.000303	CcSEcCtD
Fenofibrate—Rash—Epirubicin—testicular cancer	0.000134	0.000301	CcSEcCtD
Fenofibrate—Dermatitis—Epirubicin—testicular cancer	0.000134	0.000301	CcSEcCtD
Fenofibrate—Headache—Epirubicin—testicular cancer	0.000133	0.000299	CcSEcCtD
Fenofibrate—Dizziness—Doxorubicin—testicular cancer	0.00013	0.000292	CcSEcCtD
Fenofibrate—Nausea—Epirubicin—testicular cancer	0.000126	0.000284	CcSEcCtD
Fenofibrate—Vomiting—Doxorubicin—testicular cancer	0.000125	0.000281	CcSEcCtD
Fenofibrate—Rash—Doxorubicin—testicular cancer	0.000124	0.000279	CcSEcCtD
Fenofibrate—Dermatitis—Doxorubicin—testicular cancer	0.000124	0.000279	CcSEcCtD
Fenofibrate—Headache—Doxorubicin—testicular cancer	0.000123	0.000277	CcSEcCtD
Fenofibrate—Nausea—Doxorubicin—testicular cancer	0.000117	0.000263	CcSEcCtD
